— Know what they know.
Not Investment Advice

XOMA NASDAQ

XOMA Royalty Corp.
1W: -0.4% 1M: +6.2% 3M: +62.0% YTD: +49.4% 1Y: +57.2% 3Y: +104.0% 5Y: +39.8%
$41.65
-0.17 (-0.41%)
 
Weekly Expected Move ±6.2%
$37 $39 $42 $44 $47
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 64 · $522.3M mcap · 12M float · 1.81% daily turnover · Short 73% of daily vol

Balance Sheet Trends

Total Assets
$273M +23.2% ▲
5Y CAGR: +16.8%
Total Liabilities
$169M +21.1% ▲
5Y CAGR: +34.1%
Shareholders Equity
$104M +26.9% ▲
5Y CAGR: +3.8%
Cash & Investments
$83M -21.2% ▼
5Y CAGR: -0.3%
Total Debt
$132M +10.4% ▲
5Y CAGR: +44.0%
Net Debt
$49M +177.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$93M$58M$153M$102M$83M
Short-Term Investments$774K$335K$161K$4M$382K
Cash & ST Investments$94M$58M$153M$105M$83M
Net Receivables$209K$2M$15M$17M$5M
Inventory$0$0$0$0$0
Other Current Assets$2M$725K$643K$1M$29M
Total Current Assets$97M$61M$169M$126M$117M
Property, Plant & Equip.$213K$36K$403K$351K$277K
Goodwill & Intangibles$0$15M$0$26M$45M
Long-Term Investments$0$64M$64M$64M$106M
Other Non-Current Assets$69M$64M$533K$5M$4M
Total Non-Current Assets$70M$79M$65M$96M$155M
Total Assets$167M$140M$234M$221M$273M
— Liabilities —
Accounts Payable$1M$524K$653K$1M$2M
Short-Term Debt$0$0$6M$11M$15M
Deferred Revenue$2M$2M$2M$1M$1M
Other Current Liabilities$8M$2M$10M$3M$15M
Total Current Liabilities$13M$7M$19M$24M$35M
Long-Term Debt$0$0$119M$107M$117M
Other Non-Current Liab.$0$0$0$3M$14M
Total Non-Current Liabilities$12M$10M$126M$115M$134M
Total Liabilities$25M$16M$146M$139M$169M
— Equity —
Common Stock$85K$86K$86K$90K$89K
Retained Earnings-$1.2B-$1.2B-$1.2B-$1.2B-$1.2B
Accumulated OCI$0$0$0$73K$53K
Total Stockholders Equity$142M$124M$89M$82M$104M
Total Liabilities & Equity$167M$140M$234M$221M$273M
— Key Metrics —
Total Debt$229K$34K$124M$119M$132M
Net Debt-$93M-$58M-$29M$18M$49M
Total Investments$774K$64M$64M$68M$107M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms